| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/06/1992 | WO1992001444A1 Galenical preparation method for preparing a therapeutical composition particularly based on aspirin |
| 02/06/1992 | WO1992001442A1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 02/06/1992 | WO1992001441A1 Stable formulation of active substance |
| 02/06/1992 | WO1992001440A1 Trans-mucosal drug preparations and trans-mucosal administration |
| 02/06/1992 | WO1992001381A1 Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide |
| 02/06/1992 | DE4124481A1 Solid oral ifosfamide dosage forms |
| 02/06/1992 | CA2087596A1 Products and processes for the treatment of the alimentary canal |
| 02/06/1992 | CA2087430A1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 02/06/1992 | CA2065400A1 Method of preparing mixture of active ingredients and excipients using liquid carbon dioxide |
| 02/05/1992 | EP0470047A1 Sustained release formulations |
| 02/05/1992 | EP0469745A2 Transdermal medicine delivery apparatus |
| 02/05/1992 | EP0469520A2 Polyactide preparation and purification |
| 02/05/1992 | EP0469440A1 Solid oral administration forms containing ifosfamide as active agent |
| 02/05/1992 | EP0469328A1 Process for the preparation of small controlled release particles with a high content of Etofibrat, its use and its orally administrable forms |
| 02/05/1992 | EP0403597A4 Expandable, protein-based, low-calorie compositions |
| 02/05/1992 | CN1058341A Composition and method for topical treatment of damaged or diseased tissue |
| 02/05/1992 | CN1058337A Tablet and granulate containing sodium 2-mercaptoethanesulfonate |
| 02/04/1992 | WO1992002254A1 Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation |
| 02/04/1992 | US5086077 Endermic medicament with a gel base |
| 02/04/1992 | US5086075 Therapeutic compositions containing benzoyl peroxide |
| 02/04/1992 | US5086041 Methods of using prolonged release somatotropin compositions |
| 02/04/1992 | US5085869 Wet granulation, low water solubility with microcrystalline or microfine cellulose |
| 02/04/1992 | US5085868 Microencapsulated with wax coatings in nonaqueous oil; masking unpleasant taste, sustained release, stability |
| 02/04/1992 | US5085866 Spraying core with solution of polymer and a low boiling first solvent and a slowly evaporating second plasticizing solvent |
| 02/04/1992 | US5085865 Compressed tablet; immediate release of first layer (analgesic), second layer of hydrogel resistant to disintegration |
| 02/04/1992 | US5085864 Injectable formulation for lipophilic drugs |
| 02/04/1992 | US5085852 Powdered mixture of monoperphthalic acid derivatives, citric acid, bicarbonate and phosphate salts for mouthwashes; rapid dissolving; oral diseases |
| 02/04/1992 | US5085848 Alpha rays emission on outer surface of radioactive materials |
| 02/04/1992 | US5085749 Dynamically controlled membrane |
| 02/04/1992 | US5085634 Medicament and support |
| 02/04/1992 | US5085630 Oxygenated fluorocarbon nutrient solution |
| 02/04/1992 | US5085033 Process for preparing a solid encapsulated medicament |
| 02/04/1992 | CA2087955A1 Microcapsules having a combined atelocollagen/polyholoside wall |
| 02/04/1992 | CA1295253C Encapsulated cosmetic materials and process of making |
| 02/04/1992 | CA1295248C Powdery compound emulsifier, and its preparation and use |
| 02/04/1992 | CA1295247C Sustained release capsule |
| 02/04/1992 | CA1295245C Stable formulation of biologically active proteins for parenteral injection |
| 02/04/1992 | CA1295240C Biologically stable interferon compositions |
| 02/04/1992 | CA1295239C Pharmaceutical administration systems containing a mixture of immunomodulators |
| 02/04/1992 | CA1295238C Methods and materials for use in corneal wounds |
| 02/04/1992 | CA1295203C Smoking article with improved fuel element |
| 02/04/1992 | CA1295202C Transdermal therapeutic system |
| 02/03/1992 | WO1992002817A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 01/31/1992 | WO1992002244A1 Accumulation of amino acids and peptides into liposomes |
| 01/31/1992 | CA2087965A1 Accumulation of amino acids and peptides into liposomes |
| 01/30/1992 | DE4023593A1 Use of mixts. of poly:glycerol fatty acid ester(s) |
| 01/29/1992 | EP0468929A2 Stabilized pharmaceutical compositions |
| 01/29/1992 | EP0468875A2 Autoadhesive matrix system for transdermally controlled release of piribedil |
| 01/29/1992 | EP0468764A1 Method for administering a therapeutic anticoagulant |
| 01/29/1992 | EP0468564A2 Deodorant composition |
| 01/29/1992 | EP0468555A1 Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level |
| 01/29/1992 | EP0468436A1 Sustained-release tablet |
| 01/29/1992 | EP0468392A1 Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained |
| 01/29/1992 | EP0468327A2 Oral pharmaceutical compositions containing hirudin |
| 01/29/1992 | EP0468247A1 Process for the preparation of tablets mechanically stable and well-disintegrable, from small extrusion pellets with a high etofibrat content |
| 01/29/1992 | EP0468245A1 Tablet and granulate containing MESNA as active agent |
| 01/29/1992 | EP0468232A2 Suspending syrups |
| 01/29/1992 | EP0468199A1 Process for the preparation of poly(D,L-lactide) and its use as a drug carrier |
| 01/29/1992 | EP0468182A1 Pharmaceutical composition in powder form for nasal administration containing essentially calcitonin and a water-soluble excipient |
| 01/29/1992 | EP0468121A1 Process for the galenical preparation of a therapeutic composition, in particular based on aspirin |
| 01/29/1992 | EP0467954A1 Preparation of liposome and lipid complex compositions. |
| 01/29/1992 | EP0467916A1 Aerosolized azole antifungals |
| 01/29/1992 | EP0324794B1 Oral administration capsule with a nicotine-containing fluid medium |
| 01/29/1992 | EP0319555B1 Transdermal therapeutically effective pharmaceutical dressing and device for applying it |
| 01/29/1992 | EP0318560B1 antipsoriatic pharmaceutical composition and process for the preparation |
| 01/29/1992 | CN1058149A Stabilized fibroblast growth factor composition |
| 01/28/1992 | US5084553 Copolymers of lactic acid and tartaric acid, the production and the use thereof |
| 01/28/1992 | US5084480 Pentamidine salts useful in the treatment of pneumocystis carinii pneumonia |
| 01/28/1992 | US5084441 Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance |
| 01/28/1992 | US5084287 Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat |
| 01/28/1992 | US5084278 Drug in a core, microcapsules and polymer mixtures |
| 01/28/1992 | US5084277 Treatment of progesterone defficiency with suppositories |
| 01/28/1992 | US5084267 Sustained release compositions for treating periodontal disease |
| 01/28/1992 | CA2047861A1 Sustained release formulations |
| 01/28/1992 | CA2047543A1 Cosmetic composition |
| 01/28/1992 | CA1294963C Benzoyl urea compound |
| 01/28/1992 | CA1294885C Composition in aerosol foam form for oral hygiene |
| 01/28/1992 | CA1294879C Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone dna, and a method for administering bgh in vivo |
| 01/28/1992 | CA1294878C Composition for the extemporary preparation of formulations for topical applications for pharmaceutical and cosmetic use |
| 01/28/1992 | CA1294877C Anti-inflammatory cream composition |
| 01/28/1992 | CA1294847C Microemulsions containing perfluoropolyethers |
| 01/28/1992 | CA1294834C Particle containing a liquid-soluble active substance for release outside a human or animal body |
| 01/25/1992 | WO1992001449A1 Psychoactive drug and treatment |
| 01/25/1992 | CA2087546A1 Psychoactive drug and treatment |
| 01/25/1992 | CA2047527A1 Method for administering a therapeutic anticoagulant |
| 01/24/1992 | CA2047572A1 Suspending syrups |
| 01/24/1992 | CA2047540A1 Continuous release pharmaceutical compositions |
| 01/24/1992 | CA2047508A1 Autoadhesive matrix system for sustained transdermal release of piribedil |
| 01/24/1992 | CA2047418A1 Oral osmotic device for delivering nicotine |
| 01/23/1992 | WO1992000990A1 Interleukin receptor expression inhibiting antisense oligonucleotides |
| 01/23/1992 | WO1992000745A1 Collagen-based viscoelastic solution for visco-surgery |
| 01/23/1992 | WO1992000732A1 Therapeutical composition and process for its preparation |
| 01/23/1992 | WO1992000731A1 Pharmaceutical composition for rapid suspension in water |
| 01/23/1992 | WO1992000730A1 A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs |
| 01/23/1992 | WO1992000729A1 Dosage form for administering a drug to effect circadian therapy |
| 01/23/1992 | WO1992000728A1 Delivery device with a protective sleeve |
| 01/23/1992 | WO1992000727A1 Autobiotics and their use in eliminating nonself cells in vivo |
| 01/23/1992 | WO1992000707A1 Topical ophthalmic suspensions |
| 01/23/1992 | DE4122167A1 Neutral tasting tablets and granules contg. Mesna - contain binder, disintegrating agent, lubricant filler and opt. effervescent mixt. |
| 01/23/1992 | DE4023241A1 Stabile wirkstoff-formulierung Stable drug-formulation |